Download PDF
1 / Pages

Other users also viewed these articles

The Relevance of REMAP-ILD for Ibero-American Countries: A Randomized Embedded Multifactorial Adaptive Platform (REMAP) Trial in the Field of Interstitial Lung Diseases (ILDs) Leticia Kawano-Dourado; Maria Molina-Molina; Jacobo Sellares; Juan I. Enghelmayer;
Arch Bronconeumol. 2024;60:463-5
Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort Paloma Millan-Billi; Iván Castellví; Laura Martinez-Martinez; Anais Mariscal; Silvia Barril; Miriana D¿Alessandro; Tomás Franquet; Diego Castillo;
Arch Bronconeumol. 2024;60:350-5
Benefits of a Homecare Integral Patient Support Program in Idiopathic Pulmonary Fibrosis L. Cobo Sanchez; C. Ruiz Herrero; I. Cobos; J. Bespin; C. Gadea; P. Cerdá-Cortés; J. Palma; V. Vicens-Zygmunt; G. Bermudo; K. Portillo; A. Boldova; A. Robles; J. Arribas; J.A. Figuerola; R. Blavia; A. Moreno; D. Castillo; A. Villar; Y. Belmonte; D. Badenes-Bonet; D. Zayas; G. Suarez-Cuartin; L. Garcia-Bellmunt; J. Sellarés; S. Barril; J. Sans; M. Serra; D. Perich; L.L. Esteban; L. Esteban; E. Balcells; F. Gil; E. Ruiz; C. Fina; Maria Molina-Molina;
Arch Bronconeumol. 2023;59:526-30